US 8143297
Heterocyclic derivatives as modulators of ion channels
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8143297 (Heterocyclic derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P13/00, A61P13/02